Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04195061 · ClinicalTrials.gov registry record

Relative Sarcopenia and Cardiometabolic Risk in Young Adults With Obesity

A clinical trial of Insulin Resistance and Overweight and Obesity, sponsored by Massachusetts General Hospital.

Completed
Registry status
28
Enrollment target
1
Study location

NCT04195061 is a study of Insulin Resistance and Overweight and Obesity that has completed, run by Massachusetts General Hospital. The registered enrollment target is 28 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04195061, a study of Insulin Resistance and Overweight and Obesity, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
28 participants
Enrollment target
1
Study location

Study Summary

The goal of this research study is to learn more about the hormones that muscles make during exercise, and if those hormones are associated with type 2 diabetes risk in adults who are overweight or obese. Participants will undergo exercise testing on an upright bicycle, with blood samples taken for muscle hormones before and after exercise. The hypothesis is that adults with overweight/obesity and insulin resistance will have an impaired muscle hormone profile in response to exercise compared to adults with overweight/obesity who are not insulin resistant.

Interventions

  • PROCEDURE Cardiopulmonary exercise test (CPET)

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2019-12-12
Est. Completion 2021-11-17

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT04195061

The ClinicalTrials.gov registry entry for NCT04195061 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (89% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Insulin Resistance appearing as the primary indexed condition, and to 1 intervention - of which Cardiopulmonary exercise test (CPET) is the first listed.

NCT04195061 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04195061 about?

NCT04195061 is a clinical study titled "Relative Sarcopenia and Cardiometabolic Risk in Young Adults With Obesity". The goal of this research study is to learn more about the hormones that muscles make during exercise, and if those hormones are associated with type 2 diabetes risk in adults who are overweight or obese. Participants will undergo exercise testing on an upright bicycle, with blood samples taken for ...

What is the current status of trial NCT04195061?

This trial is currently completed. The enrollment target is 28 participants. The study started on 2019-12-12. Estimated completion is 2021-11-17.

What conditions does trial NCT04195061 study?

This clinical trial studies the following conditions: Insulin Resistance, Overweight and Obesity.

What interventions are being tested in trial NCT04195061?

The interventions under investigation include: Cardiopulmonary exercise test (CPET) (PROCEDURE).

Who is sponsoring clinical trial NCT04195061?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04195061 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insulin Resistance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.